Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2: The hoorn study

Diabetes

Volumn 49, Issue 3, 2000, Pages 485-491

  Jager, Agnes ^a   Van Hinsbergh, Victor W M ^b,d   Kostense, Piet J ^a,b   Emeis, Jef J ^d   Nijpels, Giel ^a   Dekker, Jacqueline M ^a   Heine, Robert J ^a   Bouter, Lex M ^a   Stehouwer, Coen D A ^a,b,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

EID: 0034089237     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.3.485     Document Type: Article

References (55)

1. Munro JM, Cotran RS: Biology of disease: The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 58:249-261, 1988
2. Albelda SM, Smith CW, Ward PA: Adhesion molecules and inflammatory injury. FASEB J 8:504-512, 1994
3. Springer TA: Adhesion receptors of the immune system. Nature 346:425-434, 1990
4. O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE: Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93:672-682, 1996
5. Libby P, Li H: Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis. J Clin Invest 92:538-539, 1993
6. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA: The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 128:1243-1253, 1995
7. Berlin C, Bargatze RF, Campbell JJ, von Andrian UH, Szabo MC, Hasslen SR, Nelson RD, Berg EL, Erlandsen SL, Butcher EC: Alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413-422, 1995
8. Gerszten RE, Luscinskas FW, Ding HT, Dichek DA, Stoolman LM, Gimbrone MA Jr, Rosenzweig A: Adhesion of memory lymphocytes to vascular cell adhesion molecule-1-transduced human vascular endothelial cells under simulated physiological flow conditions in vitro. Circ Res 79:1205-1215, 1996
9. Luscinskas FW, Kansas GS, Ding H, Pizcueta P, Schleiffenbaum BE, Tedder TF, Gimbrone MA Jr: Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins. J Cell Biol 125:1417-1427, 1994
10. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, McCarty J, Ferguson M, Hudkins K, Benjamin CD: Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 92:945-951, 1993
11. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf M, Katz D, Kyriakopoulos A: The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 171:223-229, 1993
12. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251:788-791, 1991
13. Li H, Cybulsky MI, Gimbrone MA, Libby P: An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 13:197-204, 1993
14. Gearing AJ, Newman W: Circulating adhesion molecules in disease. Immunol Today 14:506-512, 1993
15. Gearing AJ, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ: Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann N Y Acad Sci 667:324-331, 1992
16. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D: Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96:1395-1403, 1995
17. Jang Y, Lincoff AM, Plow EF, Topol EJ: Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 24:1591-1601, 1994
18. De Caterina R, Basta G, Lazzerini G, Dell'Omo G, Petrucci R, Morale M, Carmassi F, Pedrinelli R: Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol 17:2646-2654, 1997
19. Rohde LE, Lee RT, Rivero J, Jamacochian M, Arroyo LH, Briggs W, Rifai N, Libby P, Creager MA, Ridker PM: Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 18:1765-1770, 1998
20. Kawamura T, Umemura T, Kanai A, Uno T, Matsumae H, Sano T, Sakamoto N, Sakakibara T, Nakamura J, Hotta N: The incidence and characteristics of silent cerebral infarction in elderly diabetic patients: association with serum-soluble adhesion molecules. Diabetologia 41:911-917, 1998
21. Peter K, Nawroth P, Conradt C, Nordt T, Weiss T, Boehme M, Wunsch A, Allenberg J, Kubler W, Bode C: Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 17:505-512, 1997
22. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AMJ, Boerwinkle E: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96:4219-4225, 1997
23. Blann AD, Seigneur M, Steiner M, Miller JP, McCollum CN: Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events. Thromb Haemost 79:1080-1085, 1998
24. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J: Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351:88-92, 1998
25. Steiner M, Reinhardt KM, Krammer B, Ernst B, Blann AD: Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemost 72:979-984, 1994
26. Schmidt AM, Crandall J, Hori O, Cao R, Lakatta E: Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: a marker of vascular dysfunction and progressive vascular disease. Br J Haematol 92:747-750, 1996
27. Albertini JP, Valensi P, Lormeau B, Aurousseau MH, Ferriere F, Attali JR, Gattegno L: Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM: effect of intensive insulin treatment. Diabetes Care 21:1008-1013, 1998
28. Fasching P, Waldhausl W, Wagner OF: Elevated circulating adhesion molecules in NIDDM: potential mediators in diabetic macroangiopathy. Diabetologia 39:1242-1244, 1996
29. Otsuki M, Hashimoto K, Morimoto Y, Kishimoto T, Kasayama S: Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients. Diabetes 46:2096-2101, 1997
30. Cominacini L, Fratta Pasini A, Garbin U, Davoli A, De Santis A, Campagnola M, Rigoni A, Zenti MG, Moghetti P, Lo Cascio V: Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia 38:1122-1124, 1995
31. Bannan S, Mansfield MW, Grant PJ: Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetologia 41:460-466, 1998
32. Beks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ: Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn Study. Diabetologia 38:86-96, 1995
33. Jager A, Kostense PJ, Ruhé HG, Heine RJ, Nijpels G, Dekker JM, Bouter LM, Stehouwer CDA: Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five year follow-up of the Hoorn study. Arterioscler Thromb Vasc Biol 19:617-624, 1999
34. Hoogeveen EK, Kostense PJ, Jager A, Heine RJ, Jakobs C, Bouter LM, Donker AJM, Stehouwer CDA: Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn study. Kidney Int 54:203-209, 1998
35. Levey AS, Bosch JP, Breyer Lewis J, Greene T, Rogers N, Roth D, for the Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461-470, 1999
36. Jager A, van Hinsbergh VWM, Kostense PJ, Emeis JJ, Yudkin JS, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CDA: Von Willebrand factor, C-reactive protein and five year mortality in diabetic and non-diabetic subjects: the Hoorn study. Arterioscler Thromb Vasc Biol 19:3071-3078, 1999
37. Demattia G, Bravi MC, Laurenti O, Cassonefaldetta M, Proietti A, Deluca O, Armiento A, Ferri C: Reduction of oxidative stress by oral n-acetyl-l-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive patients with non-insulin-dependent diabetes. Diabetologia 41:1392-1396, 1998
38. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809, 1993
39. Alexander RW: Inflammation and coronary artery disease. N Engl J Med 331:468-469, 1994
40. Ahmad M, Theofanidis P, Medford RM: Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha. J Biol Chem 273:4616-4621, 1998
41. Barks JL, McQuillan JJ, Iademarco MF: TNF-alpha and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells. J Immunol 159:4532-4538, 1997
42. Stehouwer CDA, Lambert J, Donker AJM, van Hinsbergh VWM: Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 34:55-68, 1997
43. Lip GY, Blann A: Von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 34:255-265, 1997
44. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340:319-323, 1992
45. Bonomini M, Reale M, Santarelli P, Stuard S, Settefrati N, Albertazzi A: Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron 79:399-407, 1998
46. Alcalde G, Merino J, Sanz S, Zubimendi JA, Ruiz JC, Torrijos J, de Francisco AL, Cotorruelo JG, Lopez-Hoyos M, Novo MJ: Circulating adhesion molecules during kidney allograft rejection. Transplantation 59:1695-1699, 1995
47. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ: Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376:517-519, 1995
48. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
49. Hunt JV, Smith CC, Wolff SP: Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39:1420-1424, 1990
50. Smulders RA, Stehouwer CDA, Schalkwijk CG, Donker AJ, van Hinsbergh VWM, TeKoppele JM: Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus. Thromb Haemost 180:52-57, 1998
51. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D: Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. J Clin Invest 96:1395-1403, 1995
52. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM: Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92:1866-1874, 1993
53. Cominacini L, Garbin U, Pasini AF, Davoli A, Campagnola M, Contessi GB, Pastorino AM, Lo Cascio V: Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radical Bio Med 22:117-127, 1997
54. Shang XZ, Lang BJ, Issekutz AC: Adhesion molecule mechanisms mediating monocyte migration through synovial fibroblast and endothelial barriers: role for CD11/CD18, very late antigen-4, very late antigen-5, and vascular cell adhesion molecule-1. J Immunol 160:467-474, 1998
55. Menzel EJ, Neumuller J, Sengoelge G, Reihsner R: Effect of aminoguanidine on adhesion molecule expression of human endothelial cells. Pharmacology 55:126-135, 1997